Deloitte January, 2018
With the evolving industrialization of life sciences, companies need to embrace the exponential changes in technology to change the way they work, conduct research, innovate, manufacture and distribute products, and meet consumer expectations. In the US, life sciences companies can look to capitalize on opportunities brought about by further regulatory enhancements and impacts of the Tax Cuts and Jobs Act of 2017.
US lens on global trends...
Today's Sponsors
Today's Sponsor